Physician profile
Thomas Charles Beideman
NPI 1073878971
$1,881.73
in general payments reported to CMS, 2019-2025
20 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.63 · 2020: $32.64 · 2021: $59.63 · 2022: $252 · 2023: $362 · 2024: $535 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $565.62 | 2022-2025 | Puraply, Affinity, Via Matrix |
| Treace Medical Concepts, INC. | $249.99 | 2023-2025 | |
| Kerecis Limited | $234.35 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Ossio INC | $131.07 | 2022 | |
| Paragon 28, INC. | $131.00 | 2024 | Phantom Hindfoot |
| Urgo Medical North America, LLC | $71.99 | 2025 | Urgoclean Ag |
| Djo, LLC | $59.63 | 2021 | |
| Orthofix Medical, INC. | $58.31 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $57.78 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $48.02 | 2023-2024 | Dalvance |
| Paladin Technology Solutions | $41.66 | 2024 | |
| Paratek Pharmaceuticals, INC. | $37.36 | 2024 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $36.82 | 2024 | Nextremity General Instrument, Stratum Foot Plating System |
| Smith+Nephew, INC. | $35.50 | 2019-2022 | |
| Melinta Therapeutics, LLC | $33.95 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $26.29 | 2024 | Activ.A.C., V.A.C.Instill, V.A.C. Veraflo Cleanse Choice |
| Kci USA, INC. | $22.33 | 2023 | Activ.A.C., V.A.C. Dermatac |
| Misonix INC | $21.14 | 2020 | |
| Horizon Therapeutics Plc | $11.50 | 2020 | |
| Grt US Holding, INC. | $7.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Beideman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.